Glenmark Pharmaceuticals Limited (the issuer) and Citicorp International Limited, as trustee, the issuer has elected to redeem USD 10,000,000 aggregate principle amount outstanding of its 4.5% senior notes due 2021 on January 15, 2021. The Redemprion is being made pursuant to section 3.09 of the indenture and paragraph 7 of the notes. The redemption price for the redeemed notes will be 101.125% of the outstanding principle amount of the redeemed notes, plus accrued and unpaid interest thereon and additional amounts, if any, to but not including, the redemption date, and assuming that the redemption date was January 15, 2021, this will result in an aggregate payment to the holders of redeemed notes on the record date of USD 202,250, plus accrued and unpaid theron, per USD 200,000 of notes held.